 | • レポートコード：MRC-IM30413 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の止血＆組織シーリング剤市場規模は2021年に59.2億ドルに達しました。今後、2027年には92.8億ドルになり、2022年から2022年の間に年平均7.60％成長すると予測しています。本調査レポートでは、止血＆組織シーリング剤の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、製品種類別（局所止血剤、接着剤＆組織シーラント）分析、材料種類別（コラーゲンベース、酸化再生セルロース（ORC）ベース、ゼラチンベース、多糖類ベース、その他）分析、用途別（一般外科、低侵襲手術、その他）分析、エンドユーザー別（病院、ASC、在宅医療、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Advance Medical Solution Group Plc., Artivion Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson & Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Smith & Nephew plc and Terumo Corporation.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の止血＆組織シーリング剤市場規模：製品種類別 - 局所止血剤の市場規模 - 接着剤＆組織シーラントの市場規模 ・世界の止血＆組織シーリング剤市場規模：材料種類別 - コラーゲンベース止血＆組織シーリング剤の市場規模 - 酸化再生セルロース（ORC）ベース止血＆組織シーリング剤の市場規模 - ゼラチンベース止血＆組織シーリング剤の市場規模 - 多糖類ベース止血＆組織シーリング剤の市場規模 - その他材料の市場規模 ・世界の止血＆組織シーリング剤市場規模：用途別 - 一般外科用止血＆組織シーリング剤の市場規模 - 低侵襲手術用止血＆組織シーリング剤の市場規模 - その他用途の市場規模 ・世界の止血＆組織シーリング剤市場規模：エンドユーザー別 - 病院における市場規模 - ASCにおける市場規模 - 在宅医療における市場規模 - その他エンドユーザーにおける市場規模 ・世界の止血＆組織シーリング剤市場規模：地域別 - 北米の止血＆組織シーリング剤市場規模 - アジアの止血＆組織シーリング剤市場規模 - 欧州の止血＆組織シーリング剤市場規模 - 中南米の止血＆組織シーリング剤市場規模 - 中東・アフリカの止血＆組織シーリング剤市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global hemostasis and tissue sealing agents market size reached US$ 5.92 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.28 Billion by 2027, exhibiting a growth rate (CAGR) of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Hemostasis is a normal physiological response of the body, which regulates blood fluidity by stopping blood loss from the damaged blood vessel through hemostats. On the other hand, tissue sealing prevents perioperative hemorrhage and controls blood loss from damaged tissues through tissue sealing agents. Hemostats and tissue sealing agents are both used to compress blood vessels and avoid hemorrhage, blood flow, and other fluid discharge. They include thrombin sealant, fibrin glue, bovine serum or albumin, and gelatin matrix. They ensure blood fluidity and blood vessel integrity and help reduce wound healing and operative time, minimize the recovery time and hospital stay and provide better management of anticoagulated patients. They are used to disperse raw surface bleeding, bone bleeding, oozing venous bleeds, and needle-opening bleeding. At present, they are easily available in the market with varying compositions, mechanisms of action, cost, application, and adherence.
Hemostasis and Tissue Sealing Agents Market Trends:
The increasing global geriatric population and chronic medical conditions represent one of the key factors positively influencing the market. The rising participation of individuals in physical activities, along with the increasing occurrence of injuries caused during workouts and sports and physical activities, is catalyzing the demand for hemostasis and tissue sealing agents across the globe. In addition, rising cases of road accidents and gastrointestinal, pulmonary, and cardiovascular surgeries are increasing the demand for hemostats and tissue sealing. Apart from this, shifting consumer preference toward minimally invasive surgeries (MIS) for minimal incision and blood loss and faster recovery time is offering lucrative growth opportunities to manufacturers. Furthermore, leading market players are focusing on the development of multi-usage and ready-to-use products, which is expected to propel market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemostasis and tissue sealing agents market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, material type, application and end user.
Breakup by Product Type:
Topical Hemostats
Adhesive and Tissue Sealant
Breakup by Material Type:
Collagen-based
Oxidized Regenerated Cellulose (ORC) based
Gelatin-based
Polysaccharide-based
Others
Breakup by Application:
General Surgery
Minimally Invasive Surgery
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advance Medical Solution Group Plc., Artivion Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson & Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Smith & Nephew plc and Terumo Corporation.
Key Questions Answered in This Report:
How has the global hemostasis and tissue sealing agents market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hemostasis and tissue sealing agents market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the material type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hemostasis and tissue sealing agents market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hemostasis and Tissue Sealing Agents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Topical Hemostats
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Adhesive and Tissue Sealant
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Material Type
7.1 Collagen-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oxidized Regenerated Cellulose (ORC) based
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Gelatin-based
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Polysaccharide-based
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 General Surgery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Minimally Invasive Surgery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Home Care Settings
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Advance Medical Solution Group Plc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Artivion Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 B. Braun Melsungen AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Baxter International Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Becton, Dickinson & Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Integra LifeSciences Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Johnson & Johnson
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Medtronic plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Smith & Nephew plc
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Terumo Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Figure 2: Global: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Material Type (in %), 2021
Figure 6: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Application (in %), 2021
Figure 7: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by End User (in %), 2021
Figure 8: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Region (in %), 2021
Figure 9: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Hemostasis and Tissue Sealing Agents Industry: SWOT Analysis
Figure 87: Global: Hemostasis and Tissue Sealing Agents Industry: Value Chain Analysis
Figure 88: Global: Hemostasis and Tissue Sealing Agents Industry: Porter's Five Forces Analysis
• 日本語訳：止血＆組織シーリング剤の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30413 ▷ お問い合わせ（見積依頼・ご注文・質問）